undamentalytics Newsletter
Sign in

Ultralife Corp income statement

In fiscal 2025, Ultralife Corp reported revenue of $191m, up 16.2% on the year before, operating income of −$5.9m (a -3.1% margin) and net income of −$5.9m, or −$35.00 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue15416713610279667682868710710898132159164191187
Cost of revenue11912010273564753575962767974102119122145142
Gross profit354734292319232526263129252939424646
Research and development99976566557677881012
Selling, general and administrative292623221715141515151718182222242930
Operating income−4122−0−1−134677600910−6−8
Interest expense11100—————————————
Net interest income——−1−0——————————————
Income before tax−5112−1−1−2346777−0−098−8−10
Income tax0−0110000−1−18120−022−2−3
Net income−9−6−2−2−1−23482555−0−076−6−7
Diluted EPS−$0.54−$0.36−$0.12−$0.09−$0.05—$0.17$0.23$0.48$1.53$32.00$0.33$0.05$0.05$0.44$38.00−$35.00−$0.39
Diluted shares (average)17m17m17m17m17m17m16m15m16m16m16m16m16m16m16m17m17m17m
EBITDA01663216699109451313−2−4

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: ULBI vs WBXEOSE vs ULBINRGV vs ULBIFCEL vs ULBI

More: Electrical Components & Equipment stocks compared, Industrials sector, rankings of US companies

Figures from Ultralife Corp's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Ultralife Corp.